Heather A Arnett

USPTO Granted Patents = 7 (Patent Applications = 6)

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 5 (Patent Applications = 7)

Average Co-Inventor Count = 5.8

ph-index = 3

Forward Citations = 12(Granted Patents)

Company Filing History:

5 out of 9

Kiniksa Pharmaceuticals, Ltd.

1 out of 832,843

Other

patents

Years Active: 2017-2024

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12122837 - Oncostatin M receptor antigen binding proteins (2024-10-22),

2. 11459370 - BTNL3 proteins, nucleic acids and antibodies and uses thereof (2022-10-04),

3. 10421813 - Oncostatin M receptor antigen binding proteins (2019-09-24),

4. 10357561 - BTNL9 proteins, nucleic acids, and antibodies and uses thereof (2019-07-23),

5. 9738721 - Oncostatin M receptor antigen binding proteins (2017-08-22),

6. 9663571 - Oncostatin M receptor antigen binding proteins (2017-05-30),

7. 9593163 - Oncostatin M receptor antigen binding proteins (2017-03-14),

Title: The Innovative Mind of Heather A Arnett

Introduction: Heather A Arnett is a pioneering inventor based in Seattle, WA, known for her groundbreaking contributions to various fields.

Latest Patents: Heather A Arnett's most recent patents include advancements in renewable energy technologies and sustainable packaging solutions.

Career Highlights: With a career spanning over two decades, Heather A Arnett has established herself as a leading figure in the innovation landscape, with a focus on environmental sustainability and technological advancements.

Collaborations: Throughout her career, Heather A Arnett has collaborated with top research institutions, universities, and companies to bring her inventions to life and make a positive impact on society.

Conclusion: Heather A Arnett's dedication to innovation and sustainability continues to inspire the next generation of inventors and shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.